Pharmacologic and Genetic Evaluation of a C. Elegans Model for Migraine

Trial Profile

Pharmacologic and Genetic Evaluation of a C. Elegans Model for Migraine

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 25 Aug 2015

At a glance

  • Drugs Ethosuximide (Primary)
  • Indications Migraine; Migraine with aura; Migraine without aura
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 15 Feb 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
    • 24 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 09 Jan 2012 Planned end date changed from 1 Jan 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top